Earnings · China A-shares
Youcare Pharmaceutical Group Co. Ltd. Class A (688658) earnings
Youcare Pharmaceutical Group Co. Ltd. Class A published its Q3 report on 2026-10-28: net profit -37.73% year on year, -33.87% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -10.35% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -37.73%
- Excl. one-offs YoY
- -33.87%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -6.82% | — |
| 3 days | -10.35% | — |
| 7 days | -5.51% | — |
| 14 days | -14.38% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 8 reports (average -0.18%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥203.81M | -37.73% | -33.87% | -4.76% | -0.46 | -6.34% | -10.35% | — | — |
| 2026 interim report | 2026-08-21 | -¥104.90M | -6.14% | -3.74% | +1.18% | -0.24 | -3.22% | -10.91% | -13.62% | -7.92% |
| 2026 Q1 report | 2026-04-30 | -¥33.11M | +32.81% | +30.16% | -3.70% | -0.07 | -1.00% | +10.07% | -30.46% | -32.51% |
| 2025 annual report | 2026-03-21 | -¥262.39M | -312.09% | — | -35.30% | -0.59 | -7.61% | -4.19% | +18.49% | +11.31% |
| 2025 Q3 report | 2025-10-30 | -¥147.98M | -170.56% | — | -41.20% | -0.33 | -4.22% | +2.70% | +16.96% | +21.70% |
| 2025 interim report | 2025-08-29 | -¥98.83M | -183.36% | — | -40.14% | -0.22 | -2.80% | +4.22% | -19.30% | -20.57% |
| 2025 Q1 report | 2025-04-29 | -¥49.27M | -171.09% | — | -40.35% | -0.11 | -1.39% | +8.13% | +12.92% | +10.34% |
| 2024 annual report | 2025-03-15 | ¥123.72M | -33.05% | -16.33% | -9.90% | 0.28 | 3.46% | -1.08% | +2.49% | +9.50% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.